HF
BLFS icon

HRT Financial’s BioLife Solutions BLFS Stock Holding History

HRT Financial’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,966
Closed -$257K – 2879
2025
Q2 		$257K Buy
+11,966
New +$270K ﹤0.01% 1933
2024
Q4 		– Sell
-22,431
Closed -$561K – 2457
2024
Q3 		$561K Buy
+22,431
New +$530K ﹤0.01% 1539
2022
Q2 		– Sell
-20,858
Closed -$474K – 2959
2022
Q1 		$474K Sell
20,858
-61,875
-75% -$1.63M ﹤0.01% 1878
2021
Q4 		$3.08M Buy
82,733
+20,345
+33% +$873K 0.02% 456
2021
Q3 		$2.64M Buy
+62,388
New +$3M 0.02% 567

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

HRT Financial's BLFS Position: Q3 2025 in Review

HRT Financial sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 11,966 shares — an estimated $257K sold.

HRT Financial first reported a position in BLFS in Q3 2021 and held it in 5 quarters. The position peaked at $3.08M in Q4 2021. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • HRT Financial reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 11,966 BioLife Solutions shares in Q3 2025, an estimated $257K.
  • HRT Financial first reported a position in BioLife Solutions in Q3 2021 and held it in 5 quarters.
  • HRT Financial's BioLife Solutions position peaked at $3.08M in Q4 2021.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.